- In May 2022, Getinge AB increased production of its high-quality vascular grafts at its France facility to meet growing demand. This capacity boost enhances the company’s ability to supply advanced vascular repair solutions globally and strengthens its position in the regenerative medicine market.
- In December 2021, Aziyo Biologics, Inc. Aziyo Biologics secured USD 14 million in December 2021 through PIPE financing to fuel growth in regenerative medicine. The funds support R&D, manufacturing expansion, and commercialization of biologic vascular patches, enabling the company to capitalize on rising market demand
- In July 2020, LeMaitre Vascular acquired the business and assets of Artegraft, Inc. LeMaitre Vascular acquired Artegraft, Inc. in July 2020, enhancing its portfolio with biologic vascular patches. This acquisition broadened LeMaitre’s product range and strengthened its offerings for vascular repair surgeries
